 |
|
|
| |
Factors Associated With Second-Line Treatment Initiation Among Real-World, Second-Line-Eligible Patients With Primary Biliary Cholangitis in the United States
|
| |
| |
EASL 2026 May 26-30 Barcelona
Nirali Kotowsky1, Oluwadamilola Onasanya1, Rongjun Shen1, Steve Gao1
1Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
